A Phase II Study of Midostaurin and 5-Azacitidine for Untreated FLT3 Wild Type Elderly and Unfit Acute Myelogenous Leukemia Patients
Tomlinson, Benjamin K., Gallogly, Molly M., Kane, Donna M., Metheny, Leland, Lazarus, Hillard M., William, Basem M., Craig, Michael D., Levis, Mark J., Cooper, Brenda W.Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.10.018
Date:
November, 2019
File:
PDF, 1.54 MB
english, 2019